Jim Simons Medical Devices

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
MDT Medtronic PLC	$108B	$118 Million 0.19% of portfolio	1,312,641	Q3 2024 Added 106.28%
UFPT Ufp Technologies Inc	$1.91B	$88.5 Million 0.14% of portfolio	279,420	Q3 2024 Reduced 4.83%
EW Edwards Lifesciences Corp	$46.6B	$80.6 Million 0.13% of portfolio	1,221,700	Q3 2024 New
DXCM Dexcom Inc	$31B	$55.7 Million 0.09% of portfolio	830,972	Q3 2024 Added 79.64%
INMD In Mode Ltd.	$1.41B	$37.5 Million 0.06% of portfolio	2,216,418	Q3 2024 Added 7.16%
IRMD Iradimed Corp	$679M	$27.1 Million 0.04% of portfolio	539,498	Q3 2024 Reduced 3.7%
PODD Insulet Corp	$18.3B	$25.4 Million 0.04% of portfolio	109,093	Q3 2024 New
BSX Boston Scientific Corp	$130B	$21.6 Million 0.03% of portfolio	258,025	Q3 2024 New
INSP Inspire Medical Systems, Inc.	$5.36B	$21.2 Million 0.03% of portfolio	100,500	Q3 2024 Added 36.55%
TMDX Trans Medics Group, Inc.	$1.99B	$17.6 Million 0.03% of portfolio	111,799	Q3 2024 Reduced 15.24%
PEN Penumbra Inc	$9.11B	$17.5 Million 0.03% of portfolio	90,000	Q3 2024 Reduced 9.73%
ZBH Zimmer Biomet Holdings, Inc.	$22.5B	$16.5 Million 0.03% of portfolio	153,300	Q3 2024 Reduced 15.26%
SYK Stryker Corp	$140B	$16.4 Million 0.03% of portfolio	45,400	Q3 2024 New
ANIK Anika Therapeutics, Inc.	$237M	$14.2 Million 0.02% of portfolio	574,229	Q3 2024 Reduced 4.01%
NARI Inari Medical, Inc.	$2.86B	$9.6 Million 0.02% of portfolio	232,899	Q3 2024 Added 195.56%
TNDM Tandem Diabetes Care Inc	$2.38B	$8.92 Million 0.01% of portfolio	210,427	Q3 2024 Reduced 28.87%
RXST Rx Sight, Inc.	$956M	$8.81 Million 0.01% of portfolio	178,200	Q3 2024 Reduced 22.56%
ZIMV Zim Vie Inc.	$361M	$6.18 Million 0.01% of portfolio	389,200	Q3 2024 Reduced 4.23%
CNMD Conmed Corp	$2.14B	$5.51 Million 0.01% of portfolio	76,581	Q3 2024 New
LIVN Liva Nova PLC	$2.5B	$5.41 Million 0.01% of portfolio	103,094	Q3 2024 Reduced 32.35%
FONR Fonar Corp	$98.1M	$5.4 Million 0.01% of portfolio	333,516	Q3 2024 Reduced 3.11%
ARAY Accuray Inc	$175M	$5.02 Million 0.01% of portfolio	2,790,584	Q3 2024 Reduced 0.77%
GKOS Glaukos Corp	$7.2B	$4.95 Million 0.01% of portfolio	37,992	Q3 2024 Reduced 68.83%
BVS Bioventus Inc.	$657M	$4.64 Million 0.01% of portfolio	387,900	Q3 2024 Reduced 22.91%
TCMD Tactile Systems Technology Inc	$339M	$4.58 Million 0.01% of portfolio	313,200	Q3 2024 Added 4.54%
INGN Inogen Inc	$193M	$4.05 Million 0.01% of portfolio	417,900	Q3 2024 Added 17.85%
AXNX Axonics, Inc.	$3.49B	$3.75 Million 0.01% of portfolio	53,800	Q3 2024 Reduced 3.24%
BFLY Butterfly Network, Inc.	$523M	$3.7 Million 0.01% of portfolio	2,091,600	Q3 2024 Added 509.62%
BWAY Brainsway Ltd.	$154M	$3.34 Million 0.01% of portfolio	361,160	Q3 2024 Added 30.34%
VREX Varex Imaging Corp	$569M	$2.82 Million 0.0% of portfolio	236,900	Q3 2024 Reduced 0.96%
DCTH Delcath Systems, Inc.	$97.7M	$2.82 Million 0.0% of portfolio	311,800	Q3 2024 Added 276.12%
VMD Viemed Healthcare, Inc.	$299M	$2.67 Million 0.0% of portfolio	364,600	Q3 2024 Reduced 16.89%
ELMD Electromed, Inc.	$243M	$2.65 Million 0.0% of portfolio	123,404	Q3 2024 Added 19.81%
SRTS Sensus Healthcare, Inc.	$113M	$2.37 Million 0.0% of portfolio	409,334	Q3 2024 Added 4.55%
SMLR Semler Scientific, Inc.	$419M	$2.13 Million 0.0% of portfolio	90,428	Q3 2024 Added 59.2%
NVRO Nevro Corp	$133M	$1.77 Million 0.0% of portfolio	316,919	Q3 2024 Reduced 13.9%
QTRX Quanterix Corp	$394M	$1.71 Million 0.0% of portfolio	132,105	Q3 2024 Reduced 65.65%
LNSR Lensar, Inc.	$95.3M	$1.41 Million 0.0% of portfolio	307,945	Q3 2024 Reduced 5.84%
LUNG Pulmonx Corp	$233M	$1.32 Million 0.0% of portfolio	159,010	Q3 2024 Reduced 47.24%
CTKB Cytek Biosciences, Inc.	$870M	$1.17 Million 0.0% of portfolio	211,600	Q3 2024 Reduced 9.53%
MASS 908 Devices Inc.	$60M	$1.12 Million 0.0% of portfolio	322,400	Q3 2024 Added 64.91%
CERS Cerus Corp	$280M	$971,000 0.0% of portfolio	558,500	Q3 2024 Added 166.59%
ICAD Icad Inc	$42.8M	$944,000 0.0% of portfolio	601,290	Q3 2024 Added 23.67%
ATEC Alphatec Holdings, Inc.	$954M	$788,000 0.0% of portfolio	141,600	Q3 2024 Reduced 50.75%
MXCT Maxcyte, Inc.	$413M	$739,000 0.0% of portfolio	190,100	Q3 2024 Reduced 9.87%
CODX Co Diagnostics, Inc.	$24.7M	$709,000 0.0% of portfolio	567,722	Q3 2024 Reduced 3.28%
IRIX Iridex Corp	$27.7M	$695,000 0.0% of portfolio	397,360	Q3 2024 Reduced 1.88%
QIPT Quipt Home Medical Corp.	$85.3M	$631,000 0.0% of portfolio	216,300	Q3 2024 Added 24.38%
NPCE Neuro Pace Inc	$284M	$606,000 0.0% of portfolio	87,000	Q3 2024 Added 7.14%
MYO Myomo, Inc.	$44.9M	$573,000 0.0% of portfolio	143,100	Q3 2024 Added 5.93%

Shares Options

Jim Simons

Jim Simons is the founder and chairman of Renaissance Technologies, a successful investment firm that uses quantitative approaches to investing. Simons is known for his expertise in mathematical modeling and has a reputation for being a skilled and successful investor. He has generated strong returns for his clients over the long term.

Track Jim Simons's portfolio

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account